ARTICLE | Company News
Myriad Genetics, University of Wales deal
April 19, 2004 7:00 AM UTC
The university's Institute of Medical Genetics granted MYGN exclusive U.S. rights to detect mutations in Mut Y Homolog (MYH), a DNA repair gene implicated in colon cancer. MYGN will add MYH detection ...